0001140361-18-014824.txt : 20180323
0001140361-18-014824.hdr.sgml : 20180323
20180323170432
ACCESSION NUMBER: 0001140361-18-014824
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180316
FILED AS OF DATE: 20180323
DATE AS OF CHANGE: 20180323
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stagg Robert
CENTRAL INDEX KEY: 0001735050
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35993
FILM NUMBER: 18710863
MAIL ADDRESS:
STREET 1: C/O ONCOMED PHARMACEUTICALS, INC.
STREET 2: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OncoMed Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001302573
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 383572512
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-995-8200
MAIL ADDRESS:
STREET 1: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
3
1
doc1.xml
FORM 3
X0206
3
2018-03-16
0
0001302573
OncoMed Pharmaceuticals Inc
OMED
0001735050
Stagg Robert
C/O ONCOMED PHARMACEUTICALS, INC.
800 CHESAPEAKE DRIVE
REDWOOD CITY
CA
94063
0
1
0
0
SVP, Clinical R&D
Common Stock
47334
D
Stock Option (Right to Buy)
3.42
2018-12-04
Common Stock
9000
D
Stock Option (Right to Buy)
17
2023-07-16
Common Stock
5000
D
Stock Option (Right to Buy)
21.18
2024-12-17
Common Stock
35000
D
Stock Option (Right to Buy)
21.43
2025-12-26
Common Stock
30000
D
Stock Option (Right to Buy)
7.66
2027-01-02
Common Stock
55000
D
Stock Option (Right to Buy)
3.73
2027-04-22
Common Stock
60000
D
Stock Option (Right to Buy)
4.36
2027-10-06
Common Stock
36666
D
Stock Option (Right to Buy)
3.98
2028-01-03
Common Stock
70000
D
Includes 45,834 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.
The option is fully vested and exercisable.
The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of December 18, 2014, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of December 27, 2015, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of January 3, 2017, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of April 23, 2017, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of October 7, 2017, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of January 4, 2018, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
/s/ Alicia J. Hager, Attorney-in-Fact for Robert Stagg
2018-03-23